Extended use of intravenous bisphosphonate therapy for the prevention of skeletal complications in patients with cancer

Cancer Investigation

Volumn 27, Issue 10, 2009, Pages 971-977

  Wang, Xi ^a   Ni, Jing ^a   Hsu, Chen Long ^b   Johnykutty, Sharlin ^a   Tang, Ping ^a   Ho, Yuan Soon ^c   Lee, Chia Hwa ^c   Yeh, Shuyuang ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

BCa; TAP

Indexed keywords

PROTEIN; TOCOPHEROL ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LIVER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

EID: 70450212895     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900802392659     Document Type: Article

References (22)

1. Osborne, C.; Wilson, P.; Tripathy, D. Oncogenes and tumor suppressor genes in breast cancer: Potential diagnostic and therapeutic applications. Oncologist 2004, 9, 361-377.
2. Yeh, S.; Ni, J.; Chang, E.; Yin, Y.; Chen, M. Roles of vitamin E in prostate and prostate cancer. In: Prostate Cancer: Basic Mechanisms and Therapeutic Approaches New Jersey World Scientific Publishing, 2005.
3. Kline, K.; Lawson, K.A.; Yu,W.; Sanders, B.G. Vitamin E and breast cancer prevention: Current status and future potential. J Mammary Gland Biol Neoplasia 2003, 8, 91-102.
4. Zingg, J.M.; Azzi, A. Non-antioxidant activities of vitamin E. Curr Med Chem 2004, 11, 1113-1133.
5. Kimmick, G.G.; Bell, R.A.; Bostick, R.M. Vitamin E and breast cancer: A review. Nutr Cancer 1997, 27, 109-117.
6. Kline, K.; Yu, W.; Sanders, B.G. Vitamin E and breast cancer. J Nutr 2004, 134, 3458S-3462S.
7. Schwenke, D.C. Does lack of tocopherols and tocotrienols put women at increased risk of breast cancer? J Nutr Biochem 2002, 13, 2-20.
8. Malafa, M.P.; Neitzel, L.T. Vitamin E succinate promotes breast cancer tumor dormancy. J Surg Res 2000, 93, 163-170.
9. Yu, W.; Simmons-Menchaca, M.; Gapor, A.; Sanders, B.G.; Kline, K. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr Cancer 1999, 33, 26-32.
10. Anderson, K.; Simmons-Menchaca, M.; Lawson, K.A.; Atkinson, J.; Sanders, B.G.; Kline, K. Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E Succinate and vitamin E analogue, alpha-TEA. Cancer Res 2004, 64, 4263-4269.
11. Neuzil, J.; Weber, T.; Gellert, N.; Weber, C. Selective cancer cell killing by alpha-tocopheryl succinate. Br J Cancer 2001, 84, 87-89.
12. Yin, Y.; Ni, J.; Chen, M.; DiMaggio, M.A.; Guo, Y.; Yeh, S. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3. Clin Cancer Res 2007, 13, 2271-2280.
13. Weber, T.; Lu, M.; Andera, L.; Lahm, H.; Gellert, N.; Fariss, M.W.; Korinek, V.; Sattler, W.; Ucker, D.S.; Terman, A.; Schroder, A.; Erl, W.; Brunk, U.T.; Coffey, R.J.; Weber, C.; Neuzil, J. Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. Clin Cancer Res 2002, 8, 863-869.
14. Hahn, T.; Szabo, L.; Gold, M.; Ramanathapuram, L.; Hurley, L.H.; Akporiaye, E.T. Dietary Administration of the proapoptotic vitamin E analogue {alpha}-tocopheryloxyacetic acid inhibits metastatic murine breast cancer. Cancer Res 2006, 66, 9374-9378.
15. Zimmer, S.; Stocker, A.; Sarbolouki, M.N.; Spycher, S.E.; Sassoon, J.; Azzi, A. A novel human tocopherol-associated protein: Cloning, in vitro expression, and characterization. J Biol Chem 2000, 275, 25672-25680. (Pubitemid 30687071)
16. Ni, J.; Wen, X.; Yao, J.; Chang, H.C.; Yin, Y.; Zhang, M.; Xie, S.; Chen, M.; Simons, B.; Chang, P.; di Sant'Agnese, A.; Messing, E.M.; Yeh, S. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Cancer Res 2005, 65, 9807-9816.
17. Yu, K.; Toral-Barza, L.; Discafani, C.; Zhang, W.G.; Skotnicki, J.; Frost, P.; Gibbons, J.J. mTOR, a novel target in breast cancer: The effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer. Endocr Relat Cancer 2001, 8, 249-258.
18. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers inmale smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994, 330, 1029-1035.
19. Klein, E.A.; Thompson, I.M.; Lippman, S.M.; Goodman, P.J.; Albanes, D.; Taylor, P.R.; Coltman, C. SELECT: The next prostate cancer prevention trial. Selenum and vitamin E cancer prevention trial. J Urol 2001, 166, 1311-1315.
20. Miyaki, M.; Seki, M.; Okamoto, M.; Yamanaka, A.; Maeda, Y.; Tanaka, K.; Kikuchi, R.; Iwama, T.; Ikeuchi, T.; Tonomura, A.; et al. Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis. Cancer Res 1990, 50, 7166-7173.
21. Bryan, E.J.; Watson, R.H.; Davis, M.; Hitchcock, A.; Foulkes, W.D.; Campbell, I.G. Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q. Cancer Res 1996, 56, 719-721.
22. Iida, A.; Kurose, K.; Isobe, R.; Akiyama, F.; Sakamoto, G.; Yoshimoto, M.; Kasumi, F.; Nakamura, Y.; Emi, M. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer. Genes Chromosomes Cancer 1998, 21, 108-112. (Pubitemid 28081236)